Skip to content
Open access

Velociraptor Machine Learning Quantifies Similarity to Known Cell Types and Matches Cells Across Flow and Imaging Cytometry Platforms.

Sep 2026 · Cytometry Part A · 0 citations · 41 references
Medicine

TL;DR

The Velociraptor machine learning workflow for cross-platform cytometry analysis that worked effectively with both extremely rare and highly abundant cell types and with cell search labels calculated from data and theoretical labels based on literature and expertise is developed.

Abstract

Suspension flow cytometry enables high-throughput cellular profiling at the single cell level, but these data lack positional information. Conversely, tissue-based imaging cytometry techniques reveal a cell's location within the tissue architecture and can provide insight into cell biology. It would be especially valuable if data analysis tools could incorporate data from imaging and flow cytometry platforms to gain complementary strengths when quantifying features of cells and populations. We hypothesized that per-cell Marker Enrichment Modeling (MEM) might provide a way to register cells between flow and imaging cytometry analysis. Here, we developed the Velociraptor machine learning workflow for cross-platform cytometry analysis. Velociraptor begins with a graph-based implementation of MEM to calculate per-cell quantitative phenotype labels. With this information, Velociraptor can then quickly calculate similarity between each cell's phenotype and search terms describing established cell types, cells of interest, or cells observed in other samples. Velociraptor was effective in registering cells within and between cytometry platforms. Integrated identification of cell populations was tested in several challenges, including comparisons of high dimensional datasets from cancer and immunology. Tested instrument types included imaging mass cytometry (IMC), cyclic immunohistochemistry (cycIHC), suspension mass cytometry (CyTOF), and suspension spectral flow cytometry (SFC). Between IMC and CyTOF, a comparison across imaging and flow cytometry platforms that use the same mass tag probes, Velociraptor accurately identified and registered immune cell types (median F1-measure of 0.81). Between SFC and CyTOF, a comparison of two fundamentally different probe types-fluorophores and metal tags-in suspension flow cytometry, Velociraptor was even more accurate at identifying and registering cells (concordance correlation coefficient of 0.99). Velociraptor was especially useful in heterogeneous samples where individual cells diverged in phenotype from the bulk population. In IMC imaging of human breast cancer, a previously unappreciated tumor cell subset was revealed by Velociraptor, characterized as CD15+, and validated as spatially segregated to the tumor core. In both cycIHC (8-dimensional imaging) and IMC imaging (40-dimensional imaging), Velociraptor accurately identified macrophages using a single search label as input. Notably, Velociraptor worked effectively with both extremely rare and highly abundant cell types and with cell search labels calculated from data and theoretical labels based on literature and expertise. The Velociraptor algorithm is freely available at https://github.com/cytolab.

Read PDF

Similar papers

Open access Sep 2026

ConvexGating infers gating strategies from clusters in single cell cytometry data

Manual expert gating remains common practice for defining specific cell populations in flow cytometry data, but increasing numbers of measured parameters and high inter-rater variability limit consistency across studies. Cluster-based approaches use the full marker space to define cell populations more consistently, bu...

V. Friedrich, Karola Mai, T. Hofer et al. · 0 citations
Preprint Aug 2026

CytoBERT: A Foundation Model for Cytometry Data

Fine-tuning CytoBERT for sample-level classification demonstrates that transfer learning across heterogeneous cytometry datasets is feasible, providing a starting point for scalable, generalizable cytometry analysis.

S. A. Qadri, Bjarne C. Hiller, F. Blanke et al. · 0 citations
Sep 2026

FlowLOT: Linearized Optimal Transport for Flow Cytometry Analysis.

FlowLOT is introduced, an optimal-transport-based framework that models the single-cell measurement data of a pa- tient sample as an empirical cellular distribution and maps it directly into a fixed-length feature vector and unifies high-dimensional classification, interpretable visualization, and continuous quantitati...

Naqib Sad Pathan, M. Shifat-E.-Rabbi, Kristofor E. Pas et al. · 0 citations
Review Sep 2026

A Survey on the Evolution and Future Trajectory of Flow Cytometry Analysis

Flow cytometry is a powerful analytical technique that generates high-dimensional single-cell data widely used in biological research and clinical diagnostics. This survey traces the evolution of flow cytometry analysis from traditional manual gating to modern algorithmic approaches and explores emerging deep-learning...

Tony Xu, Givanna H. Putri, Aaron Chuah et al. · 0 citations
Open access Sep 2026

CytoVI: deep generative modeling of antibody-based single cell data.

Antibody-based single-cell technologies, such as flow cytometry, mass cytometry and CITE-seq, have become widely used in clinical diagnostics and basic research; however, their analysis is complicated by technical noise, batch effects, platform differences and restricted antibody panels. Here we present CytoVI, a proba...

Florian Ingelfinger, Nathan Levy, Can Ergen et al. · 0 citations
Open access Sep 2026

High-Content Imaging Workflow for Single-Cell Drug Response Profiling of Acute Myeloid Leukemia Subtypes.

Acute myeloid leukemia (AML) exhibits pronounced cellular heterogeneity, which contributes to variable therapeutic responses and limits the predictive power of conventional functional assays. While bulk viability measurements provide aggregated readouts, they fail to resolve phenotypic diversity and dynamic cellular st...

Laura Isigkeit, Rekia Sinderwald, J. Neumann et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.